Apotex Defeats Allergan's New Suit Over Pinkeye Patent
Allergan Inc. and two Japanese pharmaceutical companies on Monday failed in their renewed efforts to target Apotex Inc. for infringement of a patent used in Allergan's pinkeye treatment Zymar after a...To view the full article, register now.
Already a subscriber? Click here to view full article